Russia’s Health Ministry confirmed that the first batch of the Covid-19 vaccine developed by Russia, ‘Gam-COVID-Vac’ or Sputnik V, has been released into civil circulation. The vaccine was developed by Gamaleya National Research Center of Epidemiology and Microbiology jointly with the Russian government. The vaccine was registered and announced publicly on August 11 and is the first registered COVID vaccine in the world.
“The first batch of the ‘Gam-COVID-Vac’ [Sputnik V] vaccine for the prevention of the new coronavirus infection, developed by the Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia, has passed the necessary quality tests in the laboratories of Roszdravnadzor [medical device regulator] and has been released into civil circulation,” said the ministry in its official statement.
Moscow Mayor Sergey Sobyanin expressed the government’s hopes of vaccinating majority of Moscow citizens in the coming months. Russia’s Health Ministry has planned to have delivered batches of the vaccine in different regions of Russia shortly.
Recently, on September 7, Kirill Dmitriev, CEO of Russian Direct Investment Fund (RDIF), had confirmed that clinical trials of Sputnik V will be held in September across India, Saudi Arabia, UAE, Brazil and Philippines.
The Russian government had earlier received criticism over the decision of approving the vaccine before the third trial. But according to the preliminary results published in The Lancet journal, said Russia’s COVID-19 vaccine, Sputnik V, has been found to develop long term antibody during clinical trials.